Scarica l'app Stockscreener
2.355
7.53%
0.165
Dopo l'orario di chiusura:
2.40
0.045
+1.91%
Alx Oncology Holdings Inc Borsa (ALXO) Ultime notizie
ALX Oncology (ALXO) SVP sells 1,404 shares for RSU tax obligations - Stock Titan
ALXOAlx Oncology Holdings Inc Options - Finviz
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules - The Manila Times
ALX Oncology Appoints New Chairman Amid Leadership Changes - TipRanks
ALX Oncology grants 500,000-share option to new general counsel - Stock Titan
ALX Oncology's Corey Goodman resigns as Chairman and director - TradingView
Leadership shifts at ALX Oncology (NASDAQ: ALXO) as Garland becomes chair - Stock Titan
ALX Oncology names Scott Garland chairman, adds general counsel - Investing.com UK
ALX Oncology names Scott Garland chairman, adds general counsel By Investing.com - Investing.com India
ALXO Welcomes New Leadership with Board Changes - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel - Investing News Network
ALX Oncology appoints Scott Garland as chairman and Michael Listgarten as general counsel to strengthen leadership - Traders Union
ALX Oncology replaces its chairman and adds a new general counsel - Stock Titan
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
ALX Oncology Holdings Inc.(NasdaqGS: ALXO) added to Russell 2500 Growth Benchmark - marketscreener.com
ALX Oncology Holdings Inc. (ALXO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
ALX Oncology Holdings Inc.(NasdaqGS: ALXO) added to Russell 2000 Growth Benchmark - marketscreener.com
ALX Oncology Holdings Inc.(NasdaqGS: ALXO) added to Russell 3000E Growth Benchmark - marketscreener.com
ALX Oncology Holdings Inc.(NasdaqGS: ALXO) added to Russell 3000E Index - marketscreener.com
ALX Oncology Holdings Inc.(NasdaqGS: ALXO) added to Russell Microcap Index - marketscreener.com
ALXO Stock Edges Higher As Jefferies Conference Spotlights Oncology Pipeline - timothysykes.com
ALXO Rises As ALX Oncology Showcases Pipeline At Jefferies - StocksToTrade
Price to sales forward of ALX Oncology Holdings Inc. – NASDAQ:ALXO - TradingView
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell Small Cap Completeness Index - marketscreener.com
Alx Oncology HoldingsEnters Loan And Security Agreement With HSBC Ventures On June 25, 2026SEC Filing - TradingView
ALX Oncology Secures New $50 Million Loan Facility - TipRanks
ALX Oncology (NASDAQ: ALXO) adds up to $50M secured loan facility - Stock Titan
ALX Oncology Holdings, Inc. Actuals & Estimates (NASDAQ:ALXO) - TradingView
ALXO Forecast — Price Target — Prediction for 2027 - TradingView
ALX Oncology Holdings Inc (ALXO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ALX Oncology: Rebuilding From Critical Setbacks (NASDAQ:ALXO) - Seeking Alpha
ALXO News | ALX ONCOLOGY HOLDINGS INC (NASDAQ:ALXO) - ChartMill
ALX Oncology Holdings Inc (ALXO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ALX Oncology Holdings Inc (ALXO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ALX Oncology Holdings Inc (ALXO) Valuation: PE, PB & Fair Value Analysis - TradingKey
ALX Oncology Holdings Inc (ALXO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ALX Oncology Holdings Inc (ALXO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ALX Oncology Holdings Inc (ALXO) Institutional Confidence - TradingKey
ALX Oncology Holdings Inc (ALXO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ALX Oncology Holdings Inc (ALXO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ALXO Q1 2026 Earnings: EPS Beat Amid Pre‑Revenue Development StageMargin Guidance - newsline.com
ALX Oncology (ALXO) Edges Higher: Near-Term Support and Resistance in FocusLow Volume Node - newsline.com
ALXO Q1 2026 Earnings: EPS Surprise of 26.23% Highlights Cost Discipline Amid Clinical ProgressRevenue Recognition Risk - newsline.com
ALXO Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Shares HigherEarnings Cycle Outlook - newsline.com
ALX Oncology Shareholders Approve Directors and Executive Pay - TipRanks
ALX Oncology (NASDAQ: ALXO) holders back board slate, executive pay and KPMG audit - Stock Titan
ALX Oncology targets key readouts to advance CD47, EGFR cancer drug programs - MSN
ALXO: All voting proposals passed and clinical programs advanced, with key data expected soon - TradingView
ALX Oncology Holdings Inc Annual Shareholders Meeting Transcript - GuruFocus
ALXO Q1 2026 Earnings: EPS Beat Highlights Improved Cost Control in Pre-Revenue StageManagement Tone Analysis - newsline.com
ALXO Q1 2026 Earnings: Narrower-Than-Expected Loss Reflects Disciplined Cost ManagementFinancial Health Score - newsline.com
ALX Oncology (ALXO) Q1 2026 Earnings Transcript - AOL.com
ALXO Q1 2026 Earnings: EPS Beat Driven by Lower Expenses, Stock Slightly DownProfit Cycle Analysis - newsline.com
Insider Returns Down To US$122k As ALX Oncology Holdings' Stock Dips 15% - simplywall.st
1.18%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):